To see if local application of tranexamic acid reduces seroma formation in patients undergoing ventral hernia surgery
Phase 2
- Conditions
- Health Condition 1: K439- Ventral hernia without obstructionor gangrene
- Registration Number
- CTRI/2024/07/069878
- Lead Sponsor
- Janani Devi Colon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient having ventral hernia aged between 18 years to 80 years are included in the study. Both male and female genders are included.
Hernial Defect size more than 2cms.
patient who are able to understand the merits and demerits.
Exclusion Criteria
Patient having ventral hernia aged less than 16 years and above 80 years are excluded from the study.
Cirrhosis
Uncontrolled Diabetes Mellitus, chronic kidney disease
not willing to participate in the trial
BMI more than 35
recurrence, Strangulated hernia, pregnancy
patient with severe anaemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Seroma formation is measured in test group (using tranexamic acid) than the control group ( using normal saline)Timepoint: daily drain output till day 5 of postoperative period is estimated and compared with control group
- Secondary Outcome Measures
Name Time Method reduction of seroma formation using application of tranexamic acid compared with normal salineTimepoint: first 5 days of post operative period